Global Animal Model Market Size, Trends, and Growth Opportunity, By Animal Type (Rat, Mice, Guinea Pigs, Rabbits, and Others), By Application (Drug Discovery & Development, Basic Research, and Others), and By End User (Pharma & Biotech Companies, Academic Research Institutes, and Others), By Region and Forecast to 2030.
Global Animal Model Market
The Global Animal Model Market was valued at USD 2.25 billion in 2022 and is expected to expand to USD 3.95 billion by 2030, at a CAGR of 6.31% during the forecast period 2023-2030.
The animal model is a non-human species that is used in biomedical research because it can imitate characteristics of biological disease and processes found in humans. These models are used to study the development & progression of diseases and to test new treatments before they are given to humans. There are 3 essential types of animal models: 1. Homologous, 2. Isomorphic, 3. Predictive. There are many types of animals used in animal models such as the rat, guinea pigs, mice, rabbits, and others.
Market Drivers
The increasing demand for personalized and precision medicines, rising awareness among researchers about physiological similarities between humans & animals, rapid adoption of genetics in biomedical studies, and growing usage of animal models in pre-clinical development by many research laboratories & biopharmaceutical industries are the major factors that are expected to drive the growth of the global animal model market.
Furthermore, the rising demand for animal models for different diseases and human physiology studies is expected to boost the market over the forecast period of 2030.
Market Restraints
The high research costs and stringent regulatory frameworks can slow down market growth. Some of the other limitations and challenges that can hinder the global animal model market growth are tight legislation and standards for animal protection and welfare have limited the research techniques.
Market Segmentation
The global animal model market is segmented into animal type, application, end-user, and region.
Based on animal type, the global animal model market is segmented into the rat, mice, guinea pigs, rabbits, and others.
Based on application, the global animal model market is segmented into drug discovery & development, basic research, and others.
Based on end users, the global animal model market is segmented into pharma & biotech companies, academic research institutes, and others.
Regional Analysis
The global animal model market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
The North American region is expected to dominate the global animal model market owing to the favorable government policies reformed by the respective regulatory bodies to increase the funding plans in research plans and the growing number of investments being made in animal model research in this region. Also, growing precise medicine consumption, drug development, and increasing healthcare costs in the United States hold a large number share of the market.
Key Players
Various key players are discussed in the global animal model market report including; Horizon Discovery Group plc, Trans Genic Inc, The Jackson Laboratory, Genoway SA, Transposagen Biopharmaceuticals, Inc., Crown Bioscience, Inc., Envigo CRS SA, Eurofins Scientific SE, Charles River Laboratories International, Inc. and Taconic Biosciences, Inc.
For instance, on 28 Apr 2021, IGM Biosciences, a clinical-stage biotechnology company signed a multi-license commercial agreement within 2 years of their 1st license for the continued use of Horizon’s cGMP-compliant CHO SOURCE platform for further development of IGM’s novel therapeutic IgM antibodies.
Market Taxonomy
By Animal Type
• Rat
• Mice
• Guinea Pigs
• Rabbits
• Others
By Application
• Drug Discovery & Development
• Basic Research
• Others
By End User
• Pharma & Biotech Companies
• Academic Research Institutes
• Others
By Region
• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa
Global Animal Model Market
1 Introduction
1.1 Objective of the Study
1.2 Market Definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Animal Model Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Cumulative Impact Due To Recent Energy Crisis
4.2.5 Cumulative Impact Due Nearing Economic Downturn
4.2.6 Post Covid-19 World Supply and Demand Conditions
4.2.7 Cumulative Impact Of Russia-Ukraine Conflict
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Animal Model Market, By Animal Type
5.1 Y-o-Y Growth Comparison, By Animal Type
5.2 Global Animal Model Market Share Analysis, By Animal Type
5.3 Global Animal Model Market Size and Forecast, By Animal Type
5.3.1 Rat
5.3.2 Mice
5.3.3 Guinea Pigs
5.3.4 Rabbits
5.3.5 Others
6 Global Animal Model Market, By Application
6.1 Y-o-Y Growth Comparison, By Application
6.2 Global Animal Model Market Share Analysis, By Application
6.3 Global Animal Model Market Size and Forecast, By Application
6.3.1 Drug Discovery & Development
6.3.2 Basic Research
6.3.3 Others
7 Global Animal Model Market, By End User
7.1 Y-o-Y Growth Comparison, By End User
7.2 Global Animal Model Market Share Analysis, By End User
7.3 Global Animal Model Market Size and Forecast, By End User
7.3.1 Pharma & Biotech Companies
7.3.2 Academic Research Institutes
7.3.3 Others
8 Global Animal Model Market, By Region
8.1 Global Animal Model Market Share Analysis, By Region
8.2 Global Animal Model Market Share Analysis, By Region
8.3 Global Animal Model Market Size and Forecast, By Region
9 North America Animal Model Market Analysis and Forecast (2023-2030)
9.1 Introduction
9.2 North America Animal Model Market Share Analysis, By Animal Type
9.3 North America Animal Model Market Share Analysis, By Application
9.4 North America Animal Model Market Size and Forecast, By End User
9.5 North America Animal Model Market Size and Forecast, By Country
9.5.1 U.S.
9.5.2 Canada
9.5.3 Mexico
10 Europe Animal Model Market Analysis and Forecast (2023-2030)
10.1 Introduction
10.2 Europe Animal Model Market Share Analysis, By Animal Type
10.3 Europe Animal Model Market Share Analysis, By Application
10.4 Europe Animal Model Market Size and Forecast, By End User
10.5 Europe Animal Model Market Size and Forecast, By Country
10.5.1 Germany
10.5.2 France
10.5.3 UK
10.5.4 Rest of Europe
11 Asia Pacific Animal Model Market Analysis and Forecast (2023-2030)
11.1 Introduction
11.2 Asia Pacific Animal Model Market Share Analysis, By Animal Type
11.3 Asia Pacific Animal Model Market Share Analysis, By Application
11.4 Asia Pacific Animal Model Market Size and Forecast, By End User
11.5 Asia Pacific Animal Model Market Size and Forecast, By Country
11.5.1 China
11.5.2 Japan
11.5.3 India
11.5.4 Rest of Asia Pacific
12 Latin America Animal Model Market Analysis and Forecast (2023-2030)
12.1 Introduction
12.2 Latin America Animal Model Market Share Analysis, By Animal Type
12.3 Latin America Animal Model Market Share Analysis, By Application
12.4 Latin America Animal Model Market Size and Forecast, By End User
12.5 Latin America Animal Model Market Size and Forecast, Country
12.5.1 Brazil
12.5.2 Rest of Latin America
13 Middle East Animal Model Market Analysis and Forecast (2023-2030)
13.1 Introduction
13.2 Middle East Animal Model Market Share Analysis, By Animal Type
13.3 Middle East Animal Model Market Share Analysis, By Application
13.4 Middle East Animal Model Market Size and Forecast, By End User
13.5 Middle East Animal Model Market Size and Forecast, By Country
13.5.1 Saudi Arabia
13.5.2 UAE
13.5.3 Egypt
13.5.4 Kuwait
13.5.5 South Africa
14 Competitive Analysis
14.1 Competition Dashboard
14.2 Market Share Analysis of Top Vendors
14.3 Key Development Strategies
15 Company Profiles
15.1 Horizon Discovery Group PLC
15.1.1 Overview
15.1.2 Offerings
15.1.3 Key Financials
15.1.4 Business Segment & Geographic Overview
15.1.5 Key Market Developments
15.1.6 Key Strategies
15.2 Trans Genic Inc.
15.2.1 Overview
15.2.2 Offerings
15.2.3 Key Financials
15.2.4 Business Segment & Geographic Overview
15.25 Key Market Developments
15.2.6 Key Strategies
15.3 The Jackson Laboratory
15.3.1 Overview
15.3.2 Offerings
15.3.3 Key Financials
15.3.4 Business Segment & Geographic Overview
15.3.5 Key Market Developments
15.3.6 Key Strategies
15.4 Genoway SA
15.4.1 Overview
15.4.2 Offerings
15.4.3 Key Financials
15.4.4 Business Segment & Geographic Overview
15.4.5 Key Market Developments
15.4.6 Key Strategies
15.5 Transposagen Biopharmaceuticals, Inc.
15.5.1 Overview
15.5.2 Offerings
15.5.3 Key Financials
15.5.4 Business Segment & Geographic Overview
15.5.5 Key Market Developments
15.5.6 Key Strategies
15.6 Crown Bioscience, Inc.
15.6.1 Overview
15.6.2 Offerings
15.6.3 Key Financials
15.6.4 Business Segment & Geographic Overview
15.6.5 Key Market Developments
15.6.6 Key Strategies
15.7 Crown Bioscience, Inc.
15.7.1 Overview
15.7.2 Offerings
15.7.3 Key Financials
15.7.4 Business Segment & Geographic Overview
15.7.5 Key Market Developments
15.7.6 Key Strategies
15.8 Envigo CRS SA
15. 8.1 Overview
15.8.2 Offerings
15.8.3 Key Financials
15.8.4 Business Segment & Geographic Overview
15.8.5 Key Market Developments
15.8.6 Key Strategies
15.9 Eurofins Scientific SE
15.9.1 Overview
15.9.2 Offerings
15.4.9.3 Key Financials
15.9.4 Business Segment & Geographic Overview
15.9.5 Key Market Developments
15.9.6 Key Strategies
15.10 Charles River Laboratories International, Inc.
15.10.1 Overview
15.10.2 Offerings
15.10.3 Key Financials
15.10.4 Business Segment & Geographic Overview
15.10.5 Key Market Developments
15.10.6 Key Strategies
